Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Allogene Therapeutics (ALLO) Tax Provisions (2019)

Allogene Therapeutics' Tax Provisions history spans 1 years, with the latest figure at -$72000.0 for Q4 2019.

  • For Q4 2019, Tax Provisions changed N/A year-over-year to -$72000.0; the TTM value through Sep 2020 reached -$72000.0, changed N/A, while the annual FY2024 figure was $443000.0, N/A changed from the prior year.
  • Tax Provisions for Q4 2019 was -$72000.0 at Allogene Therapeutics, up from -$159000.0 in the prior quarter.
  • Across five years, Tax Provisions topped out at -$72000.0 in Q4 2019 and bottomed at -$159000.0 in Q2 2019.